Multicell Technologies Inc
OTC:MCET
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Multicell Technologies Inc
OTC:MCET
|
US |
|
Paradigm Medical Industries Inc
OTC:PDMI
|
US |
|
F
|
Firstfarms A/S
CSE:FFARMS
|
DK |
|
P
|
Pernod Ricard SA
DUS:PER
|
FR |
|
W
|
WPP PLC
DUS:0WP
|
UK |
|
H
|
Halliburton Co
XHAN:HAL
|
US |
|
L
|
LSI Industries Inc
F:LS2
|
US |
|
C
|
China Reinsurance (Group) Corp
F:C53
|
CN |
|
China Gold International Resources Corp Ltd
OTC:JINFF
|
CA |
|
W
|
Weir Group PLC
OTC:WEIGF
|
UK |
|
M
|
Manyo Factory Co Ltd
KOSDAQ:439090
|
KR |
|
Halliburton Co
NYSE:HAL
|
US |
|
D
|
Duke Energy Corp
XMUN:D2MN
|
US |
|
C
|
China Travel International Investment Hong Kong Ltd
XMUN:CTI
|
HK |
|
Kering SA
F:PPXB
|
FR |
|
Japan Post Bank Co Ltd
OTC:JPSTF
|
JP |
|
C
|
Carlisle Companies Inc
F:CLE
|
US |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Multicell Technologies Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Multicell Technologies Does
MultiCell Technologies, Inc. is a clinical-stage biopharmaceutical company, which engages in the provision of novel therapeutics and discovery tools that address unmet medical needs for the treatment of neurological disorders, hepatic disease and cancer. The company is headquartered in Woonsocket, Rhode Island. The firm and its subsidiaries are developing therapeutics and discovery tools for the treatment of neurological disorders, hepatic disease, cancer and interventional cardiology, and peripheral vessel applications.
- Headquarters
- United States of America US
- Employees
- 2
- IPO date
- Jun 16, 1994
